The science of nebulised drug delivery
暂无分享,去创建一个
[1] D. Cockcroft,et al. Importance of evaporative water losses during standardized nebulized inhalation provocation tests. , 1989, Chest.
[2] J. Mortensen,et al. 99Technetiumm DTPA does not break down during ultrasound nebulization , 1989 .
[3] V. Prodi,et al. Deposition of charged particles in the human airways , 1983 .
[4] H. Magnussen,et al. Variability in aerosol output of the DeVilbiss 646 jet nebulizer. , 1992, Chest.
[5] A. Wilson,et al. Dose-response effects of two sizes of monodisperse isoproterenol in mild asthma. , 1990, The American review of respiratory disease.
[6] H. Noteborn,et al. Drug delivery systems. , 1989, Current opinion in oncology.
[7] G. Smaldone. Deposition patterns of nebulized drugs: is the pattern important? , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[8] I Gonda,et al. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. , 1990, Chest.
[9] C. O’Callaghan. Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices. , 1990, Thorax.
[10] M. O'Doherty,et al. Does inhalation of pentamidine in the supine position increase deposition in the upper part of the lung? , 1990, Chest.
[11] J S Fleming,et al. A new method of quantification of the pulmonary regional distribution of aerosols using combined CT and SPECT and its application to nedocromil sodium administered by metered dose inhaler. , 1994, The British journal of radiology.
[12] J. Mauderly,et al. ANIMAL STUDIES WITH ENVIRONMENTAL AEROSOLS , 1993 .
[13] Why nebulise for more than five minutes? , 1989, Archives of disease in childhood.
[14] O. Selroos,et al. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. , 1991, Thorax.
[15] S. Clarke,et al. Effect of nebulised aerosol size on lung deposition in patients with mild asthma. , 1987, Thorax.
[16] Electrostatic lung deposition experiments with humans and animals. , 1985, The Annals of occupational hygiene.
[17] D. Hendrick,et al. Design characteristics for drug nebulizers. , 1992, Journal of medical engineering & technology.
[18] T. P. Mccarthy. Use of 'Nebuhaler' and face-mask in young asthmatic children , 1990, The Lancet.
[19] G. Smaldone,et al. Choice of mechanical ventilator: influence on nebulizer performance , 1993 .
[20] P. Morrow,et al. Chemical breakdown of technetium-99m DTPA during nebulization. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] A. Clark. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers , 1995 .
[22] B. M. Wright. A new nebuliser. , 1958, Lancet.
[23] J. Stjernswärd,et al. Lung cancer--a worldwide health problem. , 1989, Chest.
[24] I. Kellaway,et al. PARTICLE SIZE ANALYSIS OF NEBULISED AEROSOLS USING FRAUNHOFER LASER DIFFRACTION AND INERTIAL COMPACTION METHODS , 1986 .
[25] C. O’Callaghan,et al. PARADOXICAL DETERIORATION IN LUNG FUNCTION AFTER NEBULISED SALBUTAMOL IN WHEEZY INFANTS , 1986, The Lancet.
[26] J. H. Bell,et al. Variation in delivery of isoprenaline from various pressurized inhalers. , 1973, The Journal of pharmacy and pharmacology.
[27] S. S. Davis,et al. Physico-chemical studies on aerosol solutions for drug delivery I. Water-propylene glycol systems , 1978 .
[28] D. Muir,et al. Aerosol deposition and airway obstruction. , 1976, The American review of respiratory disease.
[29] G. Persson,et al. The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler). , 1989, The European respiratory journal.
[30] H. Hansson,et al. Why do medical nebulizers differ in their output and particle size characteristics? , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[31] Abramson Ha. Principles and, practice of aerosol therapy of the lungs and bronchi. , 1946 .
[32] J. H. Vincent,et al. On the practical significance of electrostatic lung deposition of isometric and fibrous aerosols , 1985 .
[33] R. Steigbigel,et al. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. , 1991, The American review of respiratory disease.
[34] G. K. Adams,et al. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma. , 1992, The Journal of allergy and clinical immunology.
[35] A. Milner,et al. Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. , 1993, Thorax.
[36] B. Lipworth,et al. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. , 1993, Thorax.
[37] S. Shire,et al. Assessment of aerosol delivery systems for recombinant human deoxyribonuclease , 1994 .
[38] S. Clarke,et al. The nasal distribution of metered does inhalers , 1987, The Journal of Laryngology & Otology.
[39] D. Pavia,et al. ASSESSMENT OF JET NEBULISERS FOR LUNG AEROSOL THERAPY , 1983, The Lancet.
[40] C. O’Callaghan,et al. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. , 1993, Thorax.
[41] T. T. Mercer,et al. Production and characterization of aerosols. , 1973, Archives of internal medicine.
[42] B. Lipworth,et al. New perspectives on inhaled drug delivery and systemic bioactivity , 1995 .
[43] M. O'Doherty,et al. Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill. , 1990, Thorax.
[44] S. Newman,et al. Lung deposition from four nebulizers. , 1993, Respiratory medicine.
[45] D. Pavia,et al. Factors influencing the size distribution of aerosols from jet nebulisers. , 1983, Thorax.
[46] P. L. Souef,et al. Dilution of nebulised aerosols by air entrainment in children , 1990, The Lancet.
[47] J. Bateman,et al. Is driving gas flow rate clinically important for nebulizer therapy? , 1986, British journal of diseases of the chest.
[48] W Stahlhofen,et al. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. , 1980, American Industrial Hygiene Association journal.
[49] M. Dahlbäck,et al. Basic nebulizer function. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[50] J. Fleming,et al. Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler. , 1985, British journal of diseases of the chest.
[51] M. O'Doherty,et al. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. , 1991, The European respiratory journal.
[52] E. Juniper,et al. Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. , 1981, The Journal of allergy and clinical immunology.
[53] M. Newhouse,et al. Aerosol penetration into the lung; influence on airway responses. , 1981, Chest.
[54] Gerald C. Smaldone,et al. Mechanisms of aerosol deposition in a nasal model , 1985 .
[55] P. L. Souëf,et al. Validity of methods used to test airway responsiveness in children , 1992, The Lancet.
[56] I. Gonda,et al. Targeting by deposition , 1992 .
[57] S. Pedersen,et al. The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler. , 1993, British journal of clinical pharmacology.
[58] D. Pavia,et al. Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. , 1986, Thorax.
[59] S. Spiro,et al. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. , 1990, Thorax.
[60] J. Mao,et al. An open, prospective comparison of beta 2 agonists given via nebuliser, Nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment. , 1995, Thorax.
[61] S. Clarke,et al. Evaluation of jet nebulisers for use with gentamicin solution. , 1985, Thorax.
[62] S. Clarke,et al. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. , 1989, Chest.
[63] S. Holgate,et al. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. , 1987, British medical journal.
[64] M. Knowles,et al. Recent advances in aerosol therapy. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[65] P. Hurley,et al. Assessment of antibiotic aerosol generation using commercial jet nebulizers. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[66] A. Milner,et al. Drug delivery from jet nebulisers. , 1992, Archives of disease in childhood.
[67] H. Chrystyn,et al. Determination of the relative bioavailability of salbutamol to the lung following inhalation. , 1992, British journal of clinical pharmacology.
[68] S. Newman,et al. Aerosol deposition considerations in inhalation therapy. , 1985, Chest.
[69] J. G. Douglas,et al. A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma. , 1986, British journal of diseases of the chest.
[70] H. Nelson,et al. Extreme variability in aerosol output of the DeVilbiss 646 jet nebulizer. , 1991, Chest.
[71] B. Lipworth,et al. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). , 1994, Thorax.
[72] I. Gonda,et al. Evaporation of aqueous aerosols produced by jet nebulizers: effects on particle size and concentration of solution in the droplets. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[73] Hatch Tf,et al. Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics. , 1966 .
[74] G. Borsboom,et al. Changes of nebulizer output over the years. , 1992, The European respiratory journal.
[75] G F Alvine,et al. Disposable jet nebulizers. How reliable are they? , 1992, Chest.
[76] D. Hendrick,et al. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. , 1990, Thorax.
[77] A. Taylor,et al. Ultrasonic Nebulisation of Fluids with Different Viscosities and Surface Tensions , 1995 .
[78] D. Geddes,et al. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. , 1991, Thorax.
[79] P. Barry,et al. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. , 1994, The European respiratory journal.
[80] D. Smith,et al. Comparison of Nebuliser Efficiency for Aerosolizing Pentamidine , 1992, The Journal of pharmacy and pharmacology.
[81] S. Clarke,et al. Wastage of drug from nebulisers: A review , 1987, Journal of the Royal Society of Medicine.
[82] G. Smaldone. Drug delivery by nebulization: "reality testing". , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[83] S. Lakshminarayan,et al. Efficiency of air compressor-driven nebulizers. , 1985, Chest.
[84] G. Rudolf,et al. Modelling and algebraic formulation of regional aerosol deposition in man , 1990 .
[85] D. Mitchell,et al. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. , 1987, Thorax.
[86] C. O’Callaghan,et al. Spacer device with face mask attachment for giving bronchodilators to infants with asthma. , 1989, BMJ.